PROVIDER PROFILE · NPI 1508013517
Everett MeyerMD PHD
PRESCRIBING · PART D · 2024
Total Rx claims
195
Beneficiaries
—
Total drug cost
$660K
Distinct drugs
8
Brand share
53.3%
Top prescribed drugs
Sulfamethoxazole/Trimethoprim54 claims
Acyclovir31 claims
Ruxolitinib Phosphate30 claims
Tacrolimus22 claims
Ibrutinib20 claims
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
REFERRAL NETWORK
Where Everett Meyer's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Lori Muffly Hematopoietic Cell Transplantation and Cellular Therapy · Stanford, CA | 13 | 84 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| STANFORD HEALTH CARE | 29 | 277 |
| Sally Arai Hematology · Stanford, CA | 13 | 134 |
| Lori Muffly Hematopoietic Cell Transplantation and Cellular Therapy · Stanford, CA | 11 | 96 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE